“‘The PBMs defense is often finger pointing, blaming exorbitant drug pricing on the manufacturers and taking no responsibility for the problem. In fact, it is the PBMs who bear a great deal of the blame, and their practices have led to severe inflation of the prices of both generic and branded medications. This limits access to needed medications for patients. It is our hope that the Committee does not let them get away with passing the buck,’” said Robert Levin, president of the Alliance for Transparent and Affordable Prescriptions (ATAP), in an emailed statement to Endpoints News.”
Taking a Stand For Patients
Taking a Stand For Patients